首页/数据集/A biobank of 30 molecularly characterized patient-derived xeongraft models of pediatric brain tumors

A biobank of 30 molecularly characterized patient-derived xeongraft models of pediatric brain tumors

NIAID Data Ecosystem2026-03-12 收录

儿科脑肿瘤异种移植

肿瘤药物研发

数据链接：

https://www.ncbi.nlm.nih.gov/geo/query/acc.cgi?acc=GSE99996 数据链接链接失效反馈

官方服务：

资源简介：

This SuperSeries is composed of the SubSeries listed below. Refer to individual Series

应用场景：

创建时间：

2021-07-25

肿瘤药物研发

肺癌脑转移治疗

Recent reports suggest that an increasing number of patients with lung cancer, especially those with activating mutations of the epidermal growth factor receptor (EGFR), also present with brain metast

NIAID Data Ecosystem20

MEK1 bound to DS03090629

药物靶点结合

肿瘤药物研发

MEK1 bound to DS03090629 Descriptor: (1~{R},3~{S})-3-[[6-[2-chloranyl-4-(4-methylpyrimidin-2-yl)oxy-phenyl]-3-methyl-1~{H}-indazol-4-yl]oxy]cyclohexan-1-amine, CALCIUM ION, DIMETHYL SULFOXIDE, ... Aut

Protein Data Bank Japan2023-11-29 更新10

Dataset from A Phase I Open-Label Dose Escalation Study of the Focal Adhesion Kinase Inhibitor, GSK2256098, in Subjects With Solid Tumors

肿瘤药物研发

I期临床试验

This study is a Phase I dose escalation study in subjects with solid tumors. Part 1 will identify the maximum tolerated dose (MTD) using a dose-escalation procedure. Following identification of the MT

NIAID Data Ecosystem00

DataSheet1_Discovery of a Series of 1,2,3-Triazole-Containing Erlotinib Derivatives With Potent Anti-Tumor Activities Against Non-Small Cell Lung Cancer.pdf

肿瘤药物研发

EGFR抑制剂优化

Epidermal growth factor receptor (EGFR) tyrosine kinase inhibitors (TKIs) are emerging at the vanguard of therapy for non-small-cell lung cancer (NSCLC) patients with EGFR-activating mutations. Howeve

NIAID Data Ecosystem20

Anti-cancer, hemolytic, and thrombolytic activity of target compounds 7a-k.

药物活性筛选

肿瘤药物研发

Anti-cancer, hemolytic, and thrombolytic activity of target compounds 7a-k.

Figshare2022-12-15 更新10